Evidence map›Paper›PMID 31311528›Full record

ArticleBMC medicine2019

Why we need a small data paradigm.

Eric B Hekler, Predrag Klasnja, Guillaume Chevance, Natalie M Golaszewski, Dana Lewis, Ida Sim

Abstract read
In one paragraph

Article in BMC medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Network dynamics of self-compassion, anxiety, and depression during eating disorder therapy.European eating disorders review : the journal of the Eating Disorders Association · 2025
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eric B HeklerCenter for Wireless & Population Health Systems, Department of Family Medicine and Public Health, Design Lab and Qualcomm Institute Faculty Member, UC San Diego, 9500 Gilman Ave, San Diego, CA, 92093, USA. ehekler@eng.ucsd.edu.
Predrag KlasnjaSchool of Information, University of Michigan, Ann Arbor, MI, USA.
Guillaume ChevanceCenter for Wireless & Population Health Systems, Department of Family Medicine and Public Health, Design Lab and Qualcomm Institute Faculty Member, UC San Diego, 9500 Gilman Ave, San Diego, CA, 92093, USA.
Natalie M GolaszewskiCenter for Wireless & Population Health Systems, Department of Family Medicine and Public Health, Design Lab and Qualcomm Institute Faculty Member, UC San Diego, 9500 Gilman Ave, San Diego, CA, 92093, USA.
Dana LewisOpenAPS, Seattle, Washington, USA.
Ida SimSchool of Medicine, UC San Francisco, San Francisco, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via various 'big data' efforts. While these methods are necessary, they are insufficient to achieve the full personalized medicine promise. A rigorous, complementary 'small data' paradigm that can function both autonomously from and in collaboration with big data is also needed. By 'small data' we build on Estrin's formulation and refer to the rigorous use of data by and for a specific N-of-1 unit (i.e., a single person, clinic, hospital, healthcare system, community, city, etc.) to facilitate improved individual-level description, prediction and, ultimately, control for that specific unit. MAIN BODY: The purpose of this piece is to articulate why a small data paradigm is needed and is valuable in itself, and to provide initial directions for future work that can advance study designs and data analytic techniques for a small data approach to precision health. Scientifically, the central value of a small data approach is that it can uniquely manage complex, dynamic, multi-causal, idiosyncratically manifesting phenomena, such as chronic diseases, in comparison to big data. Beyond this, a small data approach better aligns the goals of science and practice, which can result in more rapid agile learning with less data. There is also, feasibly, a unique pathway towards transportable knowledge from a small data approach, which is complementary to a big data approach. Future work should (1) further refine appropriate methods for a small data approach; (2) advance strategies for better integrating a small data approach into real-world practices; and (3) advance ways of actively integrating the strengths and limitations from both small and big data approaches into a unified scientific knowledge base that is linked via a robust science of causality.

conclusionSmall data is valuable in its own right. That said, small and big data paradigms can and should be combined via a foundational science of causality. With these approaches combined, the vision of precision health can be achieved.

Indexed as

Data Interpretation, StatisticalPrecision MedicineCooperative BehaviorData ScienceDatasets as TopicDelivery of Health CareHigh-Throughput Screening AssaysHumansLearningSmall-Area AnalysisArtificial intelligenceData sciencePersonalized medicinePrecision healthPrecision medicineSmall data

Identifiers

PMID31311528
PMCPMC6636023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.